BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36571590)

  • 1. Establishment and evaluation of digital PCR methods for HER2 copy number variation in breast cancer.
    Wang X; Xing D; Liu Z; Zhang Y; Cheng B; Sun S; Wang Q; Dong L
    Anal Bioanal Chem; 2023 Feb; 415(4):725-733. PubMed ID: 36571590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.
    Zhu Y; Lu D; Lira ME; Xu Q; Du Y; Xiong J; Mao M; Chung HC; Zheng G
    Exp Mol Pathol; 2016 Apr; 100(2):287-93. PubMed ID: 26626802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of HER2 amplification in formalin-fixed paraffin-embedded breast carcinoma tissue with digital PCR using two TFF3 sequences as internal reference.
    Yu R; Xuan W; Zhou L; Luo Y; Liu X; Xiong P; Ren X
    Exp Mol Pathol; 2018 Jun; 104(3):235-238. PubMed ID: 29715436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining true HER2 gene status in breast cancers with polysomy by using alternative chromosome 17 reference genes: implications for anti-HER2 targeted therapy.
    Tse CH; Hwang HC; Goldstein LC; Kandalaft PL; Wiley JC; Kussick SJ; Gown AM
    J Clin Oncol; 2011 Nov; 29(31):4168-74. PubMed ID: 21947821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Next Generation Sequencing for Detecting HER2 Copy Number in Breast and Gastric Cancers.
    Niu D; Li L; Yu Y; Zang W; Li Z; Zhou L; Jia L; Rao G; Gao L; Cheng G; Ji K; Lin D
    Pathol Oncol Res; 2020 Oct; 26(4):2577-2585. PubMed ID: 32621174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity.
    Gunn S; Yeh IT; Lytvak I; Tirtorahardjo B; Dzidic N; Zadeh S; Kim J; McCaskill C; Lim L; Gorre M; Mohammed M
    BMC Cancer; 2010 Jul; 10():396. PubMed ID: 20667129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HER2 status in breast cancer of Chinese women: a study of 1170 cases using fluorescence in-situ hybridization].
    Zeng X; Liang ZY; Wu SF; Gao J; Zhou WX; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2008 Sep; 37(9):594-8. PubMed ID: 19094582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Droplet Digital™ PCR quantitation of HER2 expression in FFPE breast cancer samples.
    Heredia NJ; Belgrader P; Wang S; Koehler R; Regan J; Cosman AM; Saxonov S; Hindson B; Tanner SC; Brown AS; Karlin-Neumann G
    Methods; 2013 Jan; 59(1):S20-3. PubMed ID: 23036330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Droplet digital PCR measurement of HER2 copy number alteration in formalin-fixed paraffin-embedded breast carcinoma tissue.
    Belgrader P; Tanner SC; Regan JF; Koehler R; Hindson BJ; Brown AS
    Clin Chem; 2013 Jun; 59(6):991-4. PubMed ID: 23358413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of a novel RT-qPCR based test for the quantification of HER2 gene expression in breast cancer.
    El Hadi H; Abdellaoui-Maane I; Kottwitz D; El Amrani M; Bouchoutrouch N; Qmichou Z; Karkouri M; ElAttar H; Errihani H; Fernandez PL; Bakri Y; Sefrioui H; Moumen A
    Gene; 2017 Mar; 605():114-122. PubMed ID: 28039034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of HER2 status in invasive breast cancers with increased centromere 17 copy number.
    Jang MH; Kim EJ; Kim HJ; Chung YR; Park SY
    Breast Cancer Res Treat; 2015 Aug; 153(1):67-77. PubMed ID: 26223814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of droplet digital PCR for quantitative and automatic analysis of the HER2 status in breast cancer patients.
    Otsuji K; Sasaki T; Tanaka A; Kunita A; Ikemura M; Matsusaka K; Tada K; Fukayama M; Seto Y
    Breast Cancer Res Treat; 2017 Feb; 162(1):11-18. PubMed ID: 28039535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability and discriminant validity of HER2 gene quantification and chromosome 17 aneusomy analysis by real-time PCR in primary breast cancer.
    Lamy PJ; Nanni I; Fina F; Bibeau F; Romain S; Dussert C; Penault Llorca F; Grenier J; Ouafik LH; Martin PM
    Int J Biol Markers; 2006; 21(1):20-9. PubMed ID: 16711510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment and significance of human epidermal growth factor receptor 2 gene status in breast cancer with polysomy of chromosome 17].
    Zhang H; Si JW; Zhang S; Wang Y; Li D; Li T
    Zhonghua Zhong Liu Za Zhi; 2016 Feb; 38(2):124-9. PubMed ID: 26899332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation.
    Whale AS; Huggett JF; Cowen S; Speirs V; Shaw J; Ellison S; Foy CA; Scott DJ
    Nucleic Acids Res; 2012 Jun; 40(11):e82. PubMed ID: 22373922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Droplet digital PCR using HER2/EIF2C1 ratio for detection of HER2 amplification in breast cancer tissues.
    Tantiwetrueangdet A; Panvichian R; Wongwaisayawan S; Sueangoen N; Lertsithichai P
    Med Oncol; 2018 Oct; 35(12):149. PubMed ID: 30284063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative RT-PCR assay of HER2 mRNA expression in formalin-fixed and paraffin-embedded breast cancer tissues.
    Park S; Wang HY; Kim S; Ahn S; Lee D; Cho Y; Park KH; Jung D; Kim SI; Lee H
    Int J Clin Exp Pathol; 2014; 7(10):6752-9. PubMed ID: 25400755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence in situ hybridization of chromosome 17 polysomy in breast cancer using thin tissue sections causes the loss of CEP17 and HER2 signals.
    Jiang H; Bai X; Zhao T; Zhang C; Zhang X
    Oncol Rep; 2014 Nov; 32(5):1889-96. PubMed ID: 25119636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nCounter CNV Assay to Detect HER2 Amplification: A Correlation Study with Immunohistochemistry and In Situ Hybridization in Advanced Gastric Cancer.
    Ahn S; Hong M; Van Vrancken M; Lyou YJ; Kim ST; Park SH; Kang WK; Park YS; Jung SH; Woo M; Lee J; Kim KM
    Mol Diagn Ther; 2016 Aug; 20(4):375-83. PubMed ID: 27179810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Content Chart-Assisted HER2/CEP17 Digital PCR Analysis of Gastric Cancer Biopsy Specimens.
    Matsusaka K; Ishikawa S; Nakayama A; Ushiku T; Nishimoto A; Urabe M; Kaneko N; Kunita A; Kaneda A; Aburatani H; Fujishiro M; Seto Y; Fukayama M
    PLoS One; 2016; 11(4):e0154430. PubMed ID: 27119558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.